← Eichor
Study identifier: NCT06244212 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Topical Treatment for Atopic Dermatitis

Condition: Atopic Dermatitis  ·  Sponsor: Wake Forest University Health Sciences

PhaseNA
Planned participants30
Who can joinAll sexes, 9 Years to no upper limit
Healthy volunteersNo

About this study

Medication adherence is a poorly studied phenomenon that challenges both patients and physicians. 50% of individuals with chronic disease are not adherent to their medication regimen. Within the United States, non-adherence to medical treatment leads to approximately $100 billion in hospital admission costs. While the issue of adherence is not limited to any particular field of medicine, non-adherence occurs in approximately one-third to one-half of dermatological patients. Non-adherence is of importance as it is a significant cause of treatment failure, resulting in worse quality of life, worse health outcomes, and increased insurance costs.

This description comes directly from the study's public registry record.

Talk to the study team

Irma Richardson, MHA  ·  336.716.2903  ·  irichard@wakehealth.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Wake Forest University Health SciencesWinston-Salem, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06244212